川普下令再度攻擊伊朗！美股道瓊暴跌953點、台積電ADR跌4.48% Ivar AI

Crypto Briefing

Trump says Iran deal ‘very close,’ could impact troop withdrawal

Crypto Briefing

US Army helicopter shot down by Iran near Strait of Hormuz, Trump confirms

The Times of India

'The Donald of Dubai': UAE billionaire close to Trump bets $66 billion on AI to become the world's data king

Diariobitcoin.com

Worldcoin desafía la tendencia bajista con un alza del 12.95% en 24 horas

Diariobitcoin.com

Audiera ($BEAT) desafía la gravedad: ¿burbuja o nuevo paradigma cripto?

Crypto Briefing

Iran closes Strait of Hormuz, warns ships will be fired upon

CNN

OpenAI files for IPO | CNN Business

Crypto Briefing

Houthis impose total naval blockade on Israel in Red Sea escalation

Yahoo Entertainment

《大賣空》本尊示警！AI三巨頭IPO募資規模超越網路泡沫

Crypto Briefing

Iran allegedly shoots down US Army Apache helicopter near Oman, triggering retaliatory strikes

Macdailynews.com

Apple’s iPhone momentum shines bright: 19.7% YoY production surge positions it for market leadership amid industry headwinds

Elespanol.com

Irán ataca Israel en represalia por su ofensiva sobre Líbano: Trump pide a Netanyahu no replicar para evitar la escalada

NPR

U.S. military says it's striking 'multiple targets' in Iran in 2nd day of renewed fire

Diariobitcoin.com

Audiera ($BEAT) explota un 91% en 24 horas y supera los USD 4 el 8 de junio de 2026

Crypto Briefing

South Pars Gas Complex petrochemical facility bombed amid escalating Iran conflict

Technews.tw

英特爾股價大漲！消息指 Alphabet 已下訂 300 萬顆晶片製造訂單

CBS News

OpenAI says it filed confidential IPO as it positions itself for AI arms race

Elespanol.com

La tecnológica OpenAI solicita confidencialmente su salida a bolsa en Estados Unidos, sin fecha estimada para ello

Yahoo Entertainment

美伊衝突再掀地緣風險美股跌逾1%科技股重挫

CBS News

U.S. launches more strikes on Iranian targets after Trump promises to hit Iran "hard"

DW (English)

EE.UU. lanza ataques contra Irán en represalia por derribo de helicóptero

$Cellectis reçoit le statut RMAT de la FDA pour lasmé-cel, la première thérapie CAR-T allogénique en essai pivot pour les patients atteints de LLA-B en rechute ou réfractaire$

GlobeNewswire

Cellectis reçoit le statut RMAT de la FDA pour lasmé-cel, la première thérapie CAR-T allogénique en essai pivot pour les patients atteints de LLA-B en rechute ou réfractaire